Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Biliary Rhabdomyosarcoma in an Infant Male With Neurofibromatosis Type 1

Alhashem, Fatema, MD*; Yilmaz, Ebru, MD*; Ozdemir, Mehmet A., MD*; Deniz, Kemal, MD; Yikilmaz, Ali, MD; Patiroglu, Turkan, MD*; Karakukcu, Musa, MD*; Unal, Ekrem, MD*

Journal of Pediatric Hematology/Oncology: January 2019 - Volume 41 - Issue 1 - p e24–e26
doi: 10.1097/MPH.0000000000001163
Online Articles: Clinical and Laboratory Observations

Different types of malignancies can be seen in patients with neurofibromatosis type 1 (NF-1). Herein we present a rare combination of NF-1 and biliary rhabdomyosarcoma in a male infant. An 11-month-old boy, who was recently diagnosed with NF-1, presented to the outpatient clinic with a 3-month history of prolonged jaundice, and failure to thrive. Clinical examination showed >20 café au let spots distributed mainly over the abdominal trunk. Hepatomegaly (4 cm below the costal margin) was additionally observed. His father was diagnosed with NF-1. Radiologic imaging studies showed a 6×5×5 cm in diameter cystic mass with multiple septations in the segment 4A of the liver. Surgical excision of the left hepatic lobe followed by hepatojejunostomy was further performed. Histopathology examination showed embryonal type rhabdomyosarcoma originating from the biliary duct. Chemotherapy regimen consisting of cyclophosphamide, actinomycin D, and vincristine, and radiotherapy were then initiated. This treatment led to a significant improvement in the patient’s clinical status, and radiologic finding portrayed attainment of complete resolution. He is still in complete remission without any sequelae for 8 years.

Departments of *Pediatrics, Division of Pediatric Hematology-Oncology


Radiology, Division of Pediatric Radiology, Faculty of Medicine, Erciyes University, Kayseri, Turkey

The authors declare no conflict of interest.

Reprints: Ekrem Unal, MD, Department of Pediatrics, Division of Pediatric Hematology-Oncology, Faculty of Medicine, Erciyes University, Melikgazi, Kayseri 38039, Turkey (e-mail:

Received June 27, 2017

Accepted January 16, 2018

Copyright © 2019 Wolters Kluwer Health, Inc. All rights reserved.